VHAQ Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Viveon Health Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.00 |
| 52 Week High | US$12.48 |
| 52 Week Low | US$0.0018 |
| Beta | -0.12 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -10.71% |
| 33 Year Change | 0.60% |
| 5 Year Change | n/a |
| Change since IPO | -1.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| VHAQ | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | -1.2% |
| 1Y | -10.7% | 55.4% | 30.4% |
Return vs Industry: VHAQ underperformed the US Capital Markets industry which returned 26.4% over the past year.
Return vs Market: VHAQ underperformed the US Market which returned 16.9% over the past year.
Price Volatility
| VHAQ volatility | |
|---|---|
| VHAQ Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VHAQ has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VHAQ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Jagi Gill | n/a |
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia.
Viveon Health Acquisition Corp. Fundamentals Summary
| VHAQ fundamental statistics | |
|---|---|
| Market cap | US$56.56m |
| Earnings (TTM) | US$1.27m |
| Revenue (TTM) | n/a |
44.7x
P/E Ratio0.0x
P/S RatioIs VHAQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VHAQ income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$1.27m |
| Earnings | US$1.27m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -28.3% |
How did VHAQ perform over the long term?
See historical performance and comparison